<DOC>
	<DOC>NCT00914641</DOC>
	<brief_summary>To estimate the pharmacokinetics of apixaban when administered as three different modified release formulation tablets relative to that when apixaban is administered as an immediate release tablet</brief_summary>
	<brief_title>Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>Healthy male or female patients Body Mass Index (BMI) of 17.5 to 30.5 kg/m2 Any condition possibly affecting drug absorption History or evidence of abnormal bleeding or clotting disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>formulation; sustained release; modified release; extended release</keyword>
</DOC>